Literature DB >> 15964156

Substance-dependent patients with and without social anxiety disorder: occurrence and clinical differences. A study of a consecutive sample of alcohol-dependent and poly-substance-dependent patients treated in two counties in Norway.

K Bakken1, A S Landheim, P Vaglum.   

Abstract

AIMS: (1) To identify clinically important differences between patients with and without social anxiety disorder (SAD) among alcohol-dependent and poly-substance-dependent patients. (2) To explore if primary SAD is a predictor of alcohol-dependency or poly-substance dependency when controlling for other Axes I and II disorders.
METHODS: A consecutive sample of in- and outpatient alcohol-dependent (N = 146) and poly-substance-dependent patients (N = 114) from public treatment programmes in two catchment areas was assessed by personal interview, the Composite International Diagnostic Interview and the Millon Clinical Multiaxial Inventory.
RESULTS: The frequency of current SAD was 42%; SAD was significantly more frequent among poly-substance-dependent patients (51%) than among alcohol-dependent patients (34%). Patients with SAD do not represent a distinct clinical subgroup, but the occurrence of SAD is combined with the occurrence of other anxiety disorders, affective disorders and personality disorders in both substance groups. The analysis showed a trend towards primary SAD as a predictor for developing poly-substance dependency.
CONCLUSIONS: Patients with SAD in both substance groups exhibited more comorbid Axis I and II disorders. They may need specific psychiatric treatment for such disorders in addition to treatment for SAD. Treatment of primary SAD could be a target for preventing poly-substance dependency in young populations.

Entities:  

Mesh:

Year:  2005        PMID: 15964156     DOI: 10.1016/j.drugalcdep.2005.04.011

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  12 in total

1.  Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  F R Schneier; T E Foose; D S Hasin; R G Heimberg; S-M Liu; B F Grant; C Blanco
Journal:  Psychol Med       Date:  2010-06       Impact factor: 7.723

2.  Severity of anxiety in mental health versus addiction treatment settings when social anxiety and substance abuse are comorbid.

Authors:  Sarah W Book; Suzanne E Thomas; Joshua P Smith; Peter M Miller
Journal:  Addict Behav       Date:  2012-05-07       Impact factor: 3.913

3.  The impact of alcohol use severity on anxiety treatment outcomes in a large effectiveness trial in primary care.

Authors:  Kate Wolitzky-Taylor; Lily A Brown; Peter Roy-Byrne; Cathy Sherbourne; Murray B Stein; Greer Sullivan; Alexander Bystritsky; Michelle G Craske
Journal:  J Anxiety Disord       Date:  2015-01-08

4.  Levetiracetam for the treatment of co-occurring alcohol dependence and anxiety: case series and review.

Authors:  John J Mariani; Frances R Levin
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

5.  Coadministration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study.

Authors:  Michael P Bogenschutz; Snehal Bhatt; Juliane Bohan; Bellelizabeth Foster; Paul Romo; Claire E Wilcox; J Scott Tonigan
Journal:  Am J Drug Alcohol Abuse       Date:  2016-05-16       Impact factor: 3.829

6.  Social anxiety impacts willingness to participate in addiction treatment.

Authors:  Sarah W Book; Suzanne E Thomas; Jared P Dempsey; Patrick K Randall; Carrie L Randall
Journal:  Addict Behav       Date:  2009-01-07       Impact factor: 3.913

7.  Why Do Those With Long-Term Substance Use Disorders Stop Abusing Substances? A Qualitative Study.

Authors:  Henning Pettersen; Anne Landheim; Ivar Skeie; Stian Biong; Morten Brodahl; Victoria Benson; Larry Davidson
Journal:  Subst Abuse       Date:  2018-02-07

8.  Axis I and II disorders as long-term predictors of mental distress: a six-year prospective follow-up of substance-dependent patients.

Authors:  Kjell Bakken; Anne Signe Landheim; Per Vaglum
Journal:  BMC Psychiatry       Date:  2007-06-26       Impact factor: 3.630

9.  An investigator-blinded, randomized study to compare the efficacy of combined CBT for alcohol use disorders and social anxiety disorder versus CBT focused on alcohol alone in adults with comorbid disorders: the Combined Alcohol Social Phobia (CASP) trial protocol.

Authors:  Andrew J Baillie; Claudia Sannibale; Lexine A Stapinski; Maree Teesson; Ronald M Rapee; Paul S Haber
Journal:  BMC Psychiatry       Date:  2013-07-30       Impact factor: 3.630

10.  Improving the retention rate for residential treatment of substance abuse by sequential intervention for social anxiety.

Authors:  Petra K Staiger; Michael Kyrios; James S Williams; Nicolas Kambouropoulos; Alexandra Howard; Stefan Gruenert
Journal:  BMC Psychiatry       Date:  2014-02-17       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.